Searched for
MANEESH PHARMACEUTICALS
Koye Pharma next on Warburg's health playGlobal private equity fund Warburg Pincus is nearing a deal to buy Koye Pharma. The Mumbai-based drugmaker focuses on women's health, respi...- US-based Warburg Pincus in talks to buy Maneesh Pharma unit in Rs 1,800 crore dealUS private equity firm Warburg Pincus is nearing a deal to buy Maneesh Pharmaceuticals' non-tuberculosis drug business. The acquisition is ...
- China’s biotech is redrawing the global pharma map; what India can learnAmerican biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma treatment. Astr...
- Sekhmet, Nirma in fray for Glenmark's API businessSekhmet Pharmaventures and Nirma Group are in competition to acquire Glenmark Life Sciences (GLS), the 82.85% subsidiary of Glenmark Pharma...
- Flat US business hits pharma stock returnsThe domestic pharma sector may have been drawing top dollar deals and driving M&As based on opportunities of growth, but stock markets seem...
- Captives likely to go on CXO hiring spreeHigh skilled talent and relatively inexpensive pros even at the senior level are the two main drivers of this trend.
- Things to consider before investing in sectoral mutual fundsThough some sectoral funds have given better returns than the equity diversified funds in the past few years, don't invest blindly in them.
- Maneesh Pharmaceutical ties up with Disney Consumer ProductsManeesh Pharmaceuticals, a leading pharamaceutical firm in India, today announced its tie-up with Disney Consumer Products to market its 'S...
- Vinay Sapte takes Maneesh Pharma to a new highFrom targeting the global relief pharma market to making 11 acquisitions in two years, Sapte's instincts never failed him.
- Maneesh Pharma buys 51% stake in US firm SynovicsManeesh has become the fourth Indian pharma firm after Sun Pharmaceuticals, Wockhardt and Glenmark, to acquire control of an American drug ...
- Maneesh buys Smyle for Rs 53 crIn a bid to strengthen its presence in India’s OTC pharmaceutical mkt, Mumbai-based Maneesh Pharmaceuticals has acquired Kopran’s brand Smy...
- Kopran on the blockThe Mumbai-based Kopran is on the block. The promoters and Clearwater Capital Partners of Cyprus, who together hold 44% equity, are believe...
- Cos slash prices of popular medicinesPopular medications to treat chest pain, anxiety, allergy and diabetes have become cheaper by between 2% and 39%.
- Unichem plans Rs 110-cr pharma buyout in BrazilMid-sized drug maker Unichem Laboratories is set to acquire a pharma company in Brazil, the fastest growing pharmaceutical market in the wo...
- Govt to force drug cos to cut pricesChemicals and fertilisers minister Ramvilas Paswan is planning to ask 11 leading pharmaceutical corporations to roll back the price increas...
Load More
